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THE ability of malignant tumours to invade neighbouring and distant tissues
is not less important in determining the outcome of cancer in the individual host
than is the question of uncontrolled proliferation. Yet the mechanism of tumour
invasiveness has received much less attention than phenomena related to tumour
growth and cell replication.
In previous investigations, an increased content of nucleases was found in
cancers of the human breast and cervix uteri and the suggestion was made that
the ability to degrade macromolecules such as nucleic acids might form an impor-
tant element in the invasive apparatus of the cancer cell (Goldberg and Pitts,
1966; Goldberg, Pitts and Ayre, 1967). Support for this suggestion was not
forthcoming from a subsequent study of human thyroid neoplasms (Goldberg
and Goudie, 1968). More recently, investigations by Sylven (1968a and b)
revealed a high content of degradative lysosomal enzymes, especially cathepsin B,
in the interstitial fluid ofsolid mouse tumour transplants, andthe author speculated
that cellular detachment by proteolytic enzymes may play an important role in
tumour invasiveness.
An opportunity to investigate this possibility further became available to us
in the course of a study of proteolytic enzymes in human intestinal epithelium,
and the results are recorded in this report.
MATERIALS AND METHODS
Segments of colon were removed from patients with colonic cancer and trans-
ported to the laboratory on ice within minutes of excision. The outer wall of
the bowel was dissected free of fat and mesenteric attachments, opened longitu-
dinally, and the contents removed with a spatula. The bowel was then thoroughly
washed with four to six rinses ofcold 025 M sucrose until free ofadherent materials.
Representative samples of tumour tissue and of bowel adjacent to the tumour
were taken for histological examination. The remainder of the uninvolved bowel
was separated from the tumour, pinned to a clean board, blotted dry, and the
mucosa lightly scraped off with the back of a scalpel and placed in cold 025 M
sucrose. Exudate and necrotic tissue was removed from the tumour if necessary
until healthy viable tumour tissue was exposed. Small pieces consisting mainly
or exclusively of epithelial tissue on naked eye examination were cored from the
tumour, chopped into cubes of approximately 1-2 mm., and placed in cold
025 M sucrose. If it was not feasible to continue the preparative procedures on
the day of collection, normal and malignant samples were snap-frozen in a bath
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of cardice and stored at -70°C. for 7-10 days. We have verified that no signifi-
cant or consistent changes in the activity or distribution ofthe enzymes measured
took place underthese conditions.
Homogenisation of the normal epithelium was achieved using a motor-driven
glass-coated teflon pestle (Sireica, New York) at a speed of 6000 r.p.m. with 20
passes over a period of two minutes. Complete homogenisation of the cancer
tissue was not possible under these conditions. A fibrous residue resistant to
further homogenisation always remained, and the amount of this residue was
quite variable in different tumours. After two minutes, the motor was stopped
with the pestle as near to the bottom of the container as possible; the well-
homogenised material above the pestle was then decanted. More sucrose was
added, and homogenisation was continued for a further two minutes when the
homogenised material was separated from the residue as before and added to the
previous homogenate. The process was repeated until no further decrease in the
residue tookplace, whenthe residue wasthendiscarded. Histological examination
of this material from several tumours revealed that it consisted mainly of fibrous
tissue, only small islands ofmalignant cells being present. All vessels used during
these procedures were cooled in ice, and an interval of at least two minutes separ-
ated individual cycles of homogenisation.
Further fractions were prepared from both normal and malignant homo-
genates according to principles previously described (Goldberg, McAllister and
Roy, 1969a), the purpose being to determine the activity and the distribution of
proteolytic enzymes in the tissues, with special reference to the percentage of
enzyme present originally in a soluble form (supernatant enzyme) and in an insol-
uble form (pellet enzyme) and the percentage that could be rendered soluble by
treating the homogenate with detergent (Nonidet increment). To this end, four
carefully measured aliquots of homogenate were placed in small homogenising
vessels. A volume of 2% (v/v) aqueous solution of Nonidet P40 (100% poly-
ethylene oxide condensate, British Drug Houses, Poole, England) was added
to two of the aliquots and the same volume of distilled water to the other two in
the ratio of nine parts homogenate to one part Nonidet or water. All four were
then re-homogenised by ten passes over one minute. One aliquot with and
one without Nonidet were centrifuged at 105,000 x g for 60 minutes in the
Superspeed 50 Refrigerated Ultracentrifuge (Measuring and Scientific Equipment,
London, England). The supernatants were quantitatively decanted and their
volumes recorded. The pellets were re-homogenised in distilled water and their
volumes noted.
The following estimations were carried out in duplicate on all homogenates,
supernatants, and resuspended pellets and repeated if the duplicates differed by
more than 15%: total nitrogen concentration according to a microkjeldahl proced-
ure (Prunty, McSwiney and Hawkins, 1959) and proteolytic activity at pH 3-75
and pH 6-50 using denatured haemoglobin (Hb) as substrate (Goldberg et al.,
1969a). The mean enzyme activity was divided by the mean nitrogen concentra-
tion to give specific enzyme activity as mg. Hb hydrolysed/hr/mg. nitrogen. The
total activity and nitrogen content of supernatant and pellet fractions could be
determined since their volumes were accuratelyknown. Thetotal enzymeactivity
of each fraction was expressed as a percentage of the total enzyme activity of its
corresponding homogenate, the aqueous supernatant and pellet being compared
with the aqueous homogenate and the Nonidet supernatant and pellet with the
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Nonidet homogenate. The amount of soluble enzyme present originally in the
supernatant and its increase after Nonidet treatment could thus be estimated.
The specific activity of the fraction solubilized by detergent (Nonidet increment)
was calculated as follows:
Total supernatant activity after Nonidet-Total
supernatant activity before Nonidet
Total supernatant nitrogen after Nonidet-Total
supernatant nitrogen before Nonidet
RESULTS
The data in Table I give the results for proteolytic activity at both pH values
as specific activities in relation to the nitrogen content ofthe fraction; in addition,
the percentage of soluble enzyme before and after detergent treatment is given.
Mean data are presented for the following tissues: cancer tissue and normal tissue
from the present series of cancer patients, and normal colonic epithelium obtained
from the unaffected bowel of subjects with Crohn's disease or ulcerative colitis
(Goldberg, McAllister and Roy, 1969b). Table I also includes results ofstatistical
comparisons between the proteolytic activities of apparently normal epithelium
from cancer patients and non-cancer patients (Column A), and proteolytic activi-
ties oftumour tissue compared with those found in uninvolved bowel from patients
with colonic cancer (Column B) and from patients with Crohn's disease orulcerative
colitis (Column C).
Comparison of two " normal " groups
Uninvolved bowel from patients with colonic cancer generally contained less
proteolytic activity than uninvolved bowel from patients with non-malignant
disease. This was virtually true ofall fractions (with the exception ofthe Nonidet
increment at pH 6.50), and was more pronounced at pH 6-50 than at pH 3-75. A
lesser percentage of the total proteolytic activity at both pH values was present
in the soluble cell supernatant of uninvolved tissue from patients with colonic
cancer, both before and after treatment with detergent; whereas the percentage
of the total activity released by detergent at pH 3-75 was similar in both groups,
only 5-7% of the total was released by detergent at pH 6-50 in the uninvolved
tissue from cancer patients compared with 12 5% in the other group.
Comparison of malignant group with " normal " groups
The outstanding feature of the cancer tissues was the reduction in proteolytic
activity at both pH values in all fractions except the Nonidet increment; here
some increase was seen, especially at pH 6-50, but the variance was very large in
all groups, and the differences were not statistically significant. The reduction
in activity was more striking relative to the " normal " tissues drawn from
patients with non-malignant disease, but was also significant at pH 3-75 relative
to " normal " tissues drawn from patients with cancer ofthe colon when the data
in the two groups were analysed by Student's t-test (Table I). These differences
were enhanced when each tumour was compared directly with adjacent uninvolved
tissue from the same patient by means of the paired t-test (Table II). Even so,
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TABLE I.-Proteolytic Activities in Fractions of Colonic Epithelium from Non-cancer (N-C)
Subjects (10 cases), from Unaffected Mucosa of Cancer (CA) Patients (20 cases) and from
Tumour Tissue (20 cases). Mean ± S.E. Values for Student's t (p) Given for Statistical
Comparison of Normal Colon from Cancer and Non-cancer Patients in Column A, Tumour
Tissue with Normal Colon from Cancer Subjects in Column B, and Tumour Tissue with
Normal Colonfrom Non-cancer Subjects in Column C.
mg. Hb hydrolysed/hour/i
pH 3-75
Normal (N-C)
Normal (CA)
Tumour
ColumnAt (p) .
Column B t (p).
Column C t (p) .
pH 6-50
Normal (N-C) .
Normal (CA)
Tumour
Column A t (p).
Column B t (p) .
Column C t (p) .
Whole
homogenate
6-13±0-72
4-92±0-34
3-68±0-23
1-67
3-00 (<0.01)
7-03 (<0-001)
0-67±0-07
0-49±0-04
0-39±0-05
2-33 (<0- 05)
1-45
5-16( <0.001)
Supernatant
10-89±1-53
8-02±0-52
6-08±0-41
2-06±(<0-05)
2-91 (<0-01)
6-42 (<0-001)
0-93±0-19
0-50±0-06
0-35±0-08
2-57 ( < 0.02)
1-44
5-38( <0-001)
mg. nitrogen % Total activity in supernatant
A, ~~~A
Nonidet Before After
Pellet increment Nonidet Nonidet
4-450- 64
3 73±0- 28
3-06±0-24
1-14
1-82
4-20 (<0-001)
1-03±0- 11
0-71±0-06
0-61+0-07
2- 59 (< 0-02)
1-08
5-34 (<0-001)
15-60±7-95 72-2±2-7 86-8±3-0
8-15±2-41 61-5±1-1 73-1±2-1
16-53±5-44 61-0 1-6 76-1±1-7
1-71 4-24(<0-001) 3-84(<0-001)
0-91 - 1-16
4-31(<0-001) 3-45(<0-01)
1-06±0- 26
1-92±0-77
5-00±3-28
1-34
0-92
0-40
37 - 7±6- 8
33-5±3- 1
22-3±4-0
0-61
2- 26 ( < 0-05)
2-10 (<0-05)
50-2±4- 7
39-2±3- 1
31 -0±4-2
1-97
1-62
2-91 (<0-01)
TABLE II.-Statistical Analysis of Data for Tumour and Uninvolved Mucosa from
20 Paired Samples of Human Colon According to the Paired t-test. Means and
S.E. for Both Groups Given in Table I. NS = Not Significant.
pH 3-75
Tumour less
Tumour greater
Both equal
to
p
pH 6-50
Tumour less
Tumour greater
Both equal .
to
p
mg. Hb hydrolysed/hour/mg. nitrogen
Whole Nonidet
homogenate Supernatant Pellet increment
14
4
1
3-71
<0-005
11
5
3
2-14
<0-05
18
1
0
3-88
<0-001
15
2
2
1-58
NS
16
3
0
2-10
<0-05
10
7
2
1-49
NS
11
8
0
0-87
NS
10
8
1
0-86
NS
% Total activity in
supermatant
Before After
Nonidet Nonidet
8
10
1
0-37
NS
14
4
1
3-14
<0-01
5
13
1
1-22
NS
15
4
0
2-46
<0-05
this treatment did not eliminate the wide scatter between and within the two
groups; for instance, the proteolytic activity at pH 6-50 was lower in the super-
natant of 15 cancers, higher in 2 and unchanged in 2 compared with uninvolved
tissue from the same patient, yet the mean difference, which averaged 30% was
not statistically significant.
The percentage of the total proteolytic activity present in the supernatant of
the cancer tissue was reduced at pH 3-75 relative to the value for the non-malig-
nant " normal " group before and after Nonidet treatment, although the percen-
tage released by Nonidet was similar in both groups. At pH 6-50, the supernatant
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activity as a percentage of the total was reduced before and after Nonidet treat-
ment relative to both " normal " groups, although once again the percentage
released by Nonidet did not differ greatly between the various groups.
In an attempt to seek clarification of the relationship, if any, between proteo-
lytic enzymes and invasiveness, the material of this study was divided into two
groups; in one, evidence of spread to the mesenteric lymph nodes or beyond was
present; in the other, no evidence of spread was obtained. The data for the two
groups are compared in Table III. No consistent pattern distinguished the two
groups, and none of the differences between them was significant.
TABLE III.- Proteolytic Activities (Mean ± S.E.) of Tumours from 12 Patients
Showing Spread to Regional Lymph Nodes Compared with Values for Tumours
from 8 Patients in whom no Evidence ofSpread was Obtained.
0% Total activity in
mg. Hb hydrolysed/hour/mg. nitrogen supernatant
Whole Nonidet Before After
homogenate Supernatant Pellet increment Nonidet Nonidet
pH 3-75
Spread 3-84±0-39 6-32±0-52 3-18±0-45 17-32±7-24 . 61-4±2-2 76-9±2-9
No spread . 3-48±0-44 5-71±0-78 2-87±0-46 5-22±9-24 59-4±2-4 74-7±2-7
pH 6 50
Spread 0-36±0-07 0-33±0-14 0-68±0-16 7-10±5-42 24.0±6-9 34-4±7-9
Nospread 0-43±0-11 0-41±01-6 0-55±0-13 2-24±1-6 . 20-1±6-8 27-0±5-2
Since all the tumours studied were adenocarcinomata, it was possible that
dilution of enzyme activity by protein-containing enzyme-free mucus might have
been a factor in reducing the specific enzyme activity relative to protein, at least
in the supernatant fraction of the tumours. To test this possibility, the tumours
were classified on the basis of histological examination into three groups: well-
differentiated, poorly-differentiated, and an intermediate group. The super-
natant activities are presented in Table IV. If mucus production were an impor-
TABLE IV.-CoMparison of Proteolytic Activities (mg. Hb hydrolysed/hour/mg.
Nitrogen) in Supernatant Fraction of Adenocarcinomata of Colon Classified
as Well-differentiated (5 samples), Poorly-differentiated (5 Samples) and Inter-
mediate (10 Samples). Results as Mean ± S.E.
pH 3-75 pH 6 50
Well-differentiated 7-42 1-41 038±0-16
Intermediate 6-01±1-32 038±0-12
Poorly-differentiated 4-78±1-59 027±0-13
tant factor in reducing supernatant enzyme activities ofadenocarcinomata, poorly-
differentiated tumours should have a higher specific activity in this fraction than
well-differentiated tumours. In fact the opposite trend is apparent from the data,
although the differences are not statistically significant due possibly to the small
size of the various groups.
DISCUSSION
Normal human colonic epithelium contains proteolytic activity maximally
active at pH 3-75 using Hb as substrate, and mainly associated with the super-
natant fraction; detergent releases approximately half the activity originally
739D. M. GOLDBERG, R. A. MCALLISTER AND A. D. ROY
associated with insoluble fractions (Goldberg et al., 1969a). Evidence obtained
from pH activity curves and study ofpurified cell fractions indicated the probable
existence of a second enzyme, more intimately associated with insoluble fractions,
which, while optimally active at acid pH, still has considerable activity at pH
6*50 (Goldberg et al., 1969a). There does not seem to be a marked difference
between normal and malignant epithelium in this respect, the pH activity curves
obtained from both being similar (Fig. 1). This validates the comparison between
proteol ytiO
.P .*.
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FIG. 1.-pH activity curves for proteolytic activity of fractions prepared from paired samples
of uninvolved mucosa (solid circles) and adenocarcinoma (open circles). Buffers were
0 1 M acetate (pH 20 to 50) and 01 M phosphate (pH 5.5 to 7-5). Fractions are Homogenate
(A), Supernatant (B) and Pellet (C). Activity ofeach normal fraction at pH 4-0 is taken as
100.
normal and malignant tissues at the two pH values chosen, a useful precaution
when investigating an ill-defined enzyme or group of enzymes active over a wide
pH range, since mouse ascites tumours have a pH proffle for ribonuclease which
differs from that ofnormal mouse tissues (Colter, Kuhn and Ellem, 1961), and the
pH activity curve for ribonuclease in hyperplastic human thyroid tissue was not
identical with that of the normal gland (Goldberg and Goudie, 1968).
The existence ofa proteolytic enFyme similar to the cathepsin D ofbeefspleen
(Press, Porter and Cebra, 1960) and of rabbit spleen (Lapresle and Webb, 1960,
1962) has been demonstrated in guinea-pig intestinal mucosa (Kregar, Turk and
Lebez, 1967). Proteolytic enzymes of rat intestinal mucosa were found to be
associated with lysosomes (Hsu and Tappel, 1964). It is unlikely that either of
the two proteolytic activities measured in this work are lysosomal, despite the
high specific activity of the Nonidet increment. Detergent did not increase the
specific activity of the homogenate through activation of latent enzyme, but
merely solubilised a small percentage (6%-15%) which happened to be present
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in the particles in a fully active form. It is likely that much of this activity orig-
inated in mitochondria which are known to be major sources ofproteolytic enzymes
(Alberti and Bartley, 1963, 1965, 1969). Mitochondria may be prepared in high
yield from human colonic epithelium, but electron microscope studies on purified
subcellular fractions show few organelles corresponding to lysosomes (Goldberg,
Campbell and Roy, 1969); the paucity of lysosomes in human colonic epithelium
was confirmed by electron microscope analysis of the fine structure of fresh
surgical material (R. F. Macadam, personal communication).
Raised levels of proteolytic enzymes (Sylven and Bois-Svenssen, 1965) and of
dipeptidases (Wu and Bauer, 1963) have been found in rodent tumours. These
observations are compatible with speculation that proteolytic enzymes may play
a role in tumour invasiveness (Sylven, 1968a, 1968b) and that release oflysosomal
hydrolases might be concerned in cancer induction (Allison, 1966). Neither
possibility finds support in the present work, since activity in all fractions was
reduced in the cancers relative to two series of non-malignant tissues. We have
previously shown reduced levels ofproteolytic enzymes in colonic mucosa affected
by non-malignant inflammatory diseases such as ulcerative colitis (Goldberg,
McAllister and Roy, 1.969b). Reduced levels of respiratory enzymes have been
demonstrated by histochemical analysis of regenerating human colonic mucosa
(Melnyk, Braucher and Kirsner, 1967). Certain oxidative enzymes, including
succinic dehydrogenase, appear to be reducedinhumancolonic cancer(Wattenberg,
1959a, 1959b), and reduction in the aldolase content of human colonic tumours
has also been reported (Dale, 1965). Although there is some basis in these reports
for the view that loss ofrespiratory and degradative enzymes may be a non-specific
response on the part of colonic mucosa to injury or disease, to regeneration or to
increased cell turnover, the overall picture is by no means so consistent. For
example, Dale (1965) found colonic cancer to have increased levels of lactate
dehydrogenase and deoxyribonuclease II when enzyme activities were measured
in relation to DNA content; activities of lactate dehydrogenase, malate dehydro-
genase and enolase were raised in adenocarcinomata of the human colon relative
to adjacent uninvolved tissue (Ames, Albaum and Antopol, 1964). Increased
lactate dehydrogenase activity in human colonic cancer was also reported by
Goldman, Kaplan and Hall (1964). In an extensive study, Shonk and colleagues
found an increased content of most glycolytic enzymes in human colonic cancer,
but reduced levels of phosphofructokinase, fructose-1,6-diphosphatase and alpha-
glycerophosphate dehydrogenese were also noted (Shonk, Arison, Koven, Majima
and Boxer, 1965). At the present time, it is therefore not possible to fit the obser-
vations in this report into a coherent and unified concept of metabolism in the
cancer cell generally, or in colonic cancer as a specific entity.
The problem of cancer investigation in the human subject is rendered difficult
by the lack of access to suitable control material. This problem has been emphas-
ised in the present work through the wide differences existing between apparently
normal tissue obtained at operation from patients with malignant and non-malig-
nant bowel lesions. We cannot say with certainty whether the uninvolved tissue
from cancer patients has less proteolytic activity than normal, or whether the
uninvolved tissue from patients with inflammatory bowel diseases has higher
activity than normal. The simple truth is that we do not know the characteristics
of "normal" tissue. Since ulcerative colitis is associated with marked protein
loss in the bowel (Steinfeld, Davidson and Gordon, 1957; Soergel and Ingelfinger,
60
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1961), changes in serum proteins (Bicks, Kirsner and Palmer, 1959; De Dombal,
1968), and functional impairment of abdominal organs such as the liver (Vinnick,
Kern and Corley, 1963) and pancreas (Ball, Baggenstoss and Bargen, 1950), in
addition to the well known involvement of distant sites manifested by arthritis
and occular changes, it is to be expected that subtle changes in cell metabolism
manifested by altered enzyme levels might be present in morphologically normal
adjacent bowel tissue. Similar considerations apply to cancer patients; indeed
altered levels of certain enzymes of carbohydrate metabolism were found in the
livers ofpatients with gastro-intestinal carcinomas without hepatic spread (Dacha,
Catterina and Fornaini, 1963). The use of autopsy material has other dangers.
Although most glycolytic enzymes have comparable activities in surgical and
autopsy specimens, others such as phosphofructokinase rapidly lose activity in the
latter (Shonk, Majima, Koven and Boxer, 1966). The effect of anoxia on acid
hydrolases (De Duve and Beaufay, 1959) would render such material unsuitable
for the study ofthe cytoplasmic distribution ofproteolytic enzymes.
Although the biochemical features that distinguish malignant from normal
tissue are a long way from being defined for the human subject, descriptive studies
such as the present may contribute data on a small aspect which, when fitted into
the pattern of future work, may one day permit this important distinction to be
made.
SUMMARY
Proteolytic activities determined by the hydrolysis of denatured haemoglobin
at pH 3-75 and pH 6-50 have been measured in 20 adenocarcinomata ofthe human
colon and the neighbouring uninvolved mucosa from the same patients. Reduced
activities were found in soluble and insoluble cell fractions ofthe tumours at both
pH values. The reduction could not be related to the degree of differentiation of
the tumour or its invasiveness as gauged by spread to neighbouring lymph nodes.
Proteolytic activities in the uninvolved mucosa of cancer patients were decreased
compared with the levels found in ten samples ofuninvolved mucosa from patients
with inflammatory disease ofthe colon. The distribution ofactivities was studied
before and after treatment of the homogenates with the detergent Nonidet P40.
The percentage of the homogenate activity present in a soluble form was dimin-
ished at both pH values in the cancers both before and after Nonidet treatment,
relative to uninvolved mucosa from non-cancer subjects; the samples ofuninvolved
mucosa from cancer subjects were intermediate between the above two groups in
this respect. Although the reduced proteolytic activities ofhuman colonic cancers
seems established by this work, the characteristics of normal colonic mucosa are
difficult to define in view of significant differences between the two control
populations studied.
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